![Rudolf Beck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Rudolf Beck first degree
Entity | Entity type | Industry | |
---|---|---|---|
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
26
| Subsidiary | Pharmaceuticals: Major | 26 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rudolf Beck via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Director of Finance/CFO Corporate Officer/Principal | |
SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PITNEY BOWES INC. | Information Technology Services | Chief Tech/Sci/R&D Officer | |
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Pulmatrix Operating Co., Inc.
![]() Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
RADIUS HEALTH, INC. | Biotechnology | Chairman | |
DNIB UNWIND INC | Biotechnology | Director/Board Member | |
TARIS BioMedical LLC
![]() TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member | |
KALA BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Nimbus Therapeutics LLC
![]() Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Oxeia Biopharmaceuticals, Inc.
![]() Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals UK Ltd.
![]() Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Endo Pharmaceuticals, Inc.
![]() Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
Astra Merck, Inc.
![]() Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | President Director/Board Member Corporate Officer/Principal | |
Ball State University (Indiana) | College/University | Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Masters Business Admin Doctorate Degree | |
Hillsdale College | College/University | Undergraduate Degree | |
New York University | College/University | Doctorate Degree Undergraduate Degree | |
Intarcia Therapeutics, Inc.
![]() Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Chief Executive Officer | |
VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Nanjing University | College/University | Undergraduate Degree Graduate Degree | |
Nabriva Therapeutics GmbH
![]() Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
MERUS N.V. | Biotechnology | Director/Board Member | |
Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal Sales & Marketing General Counsel Corporate Officer/Principal | ||
Bryant University | College/University | Masters Business Admin Undergraduate Degree | |
Akamis Bio Ltd.
![]() Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Civitas Therapeutics, Inc.
![]() Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Chief Executive Officer | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member | |
Alevium Pharmaceuticals, Inc. | Director/Board Member | ||
SERES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Executive Officer | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Financial Executives International Philadelphia Chapter | Director/Board Member | ||
PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Nimbus Apollo, Inc.
![]() Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Wellesley Youth Hockey Association
![]() Wellesley Youth Hockey Association Movies/EntertainmentConsumer Services Wellesley Youth Hockey Association is a sports organization that promotes ice hockey and values such as sportsmanship, teamwork, and respect for the rules of play. The association is based in Wellesley, Massachusetts. The association offers various programs for different age groups, including travel teams, mite programs, and goalie training. It also provides resources for coaches, officials, and parents. | Movies/Entertainment | Director/Board Member | |
I2o Therapeutics, Inc.
![]() I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Ascletis Pharmaceuticals Co., Ltd. | Corporate Officer/Principal |
Statistics
International
United States | 40 |
United Kingdom | 4 |
Japan | 2 |
Switzerland | 2 |
France | 2 |
Sectoral
Health Technology | 36 |
Consumer Services | 8 |
Technology Services | 2 |
Distribution Services | 2 |
Retail Trade | 2 |
Operational
Director/Board Member | 101 |
Corporate Officer/Principal | 75 |
Independent Dir/Board Member | 39 |
Chairman | 26 |
President | 25 |
Most connected contacts
Insiders | |
---|---|
Wayne P. Yetter | 28 |
Mark Iwicki | 26 |
Thomas Paul Koestler | 26 |
Charles Rowland | 25 |
Mark A. Pulido | 23 |
Jinzi Wu | 20 |
Georgia Keresty | 15 |
Kurt Graves | 15 |
Geoffrey Nichol | 14 |
Dagmar Rosa-Bjorkeson | 12 |
Michael Newman | 12 |
Cheng Shi | 11 |
Michael McGrane | 8 |
Wouter W. Latour | 8 |
Carol Lynch | 7 |
- Stock Market
- Insiders
- Rudolf Beck
- Company connections